Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Omnibus permutation tests of the overall null hypothesis in datasets with many covariates.
Potter DM, Griffiths DJ. Potter DM, et al. J Biopharm Stat. 2006 May;16(3):327-41. doi: 10.1080/10543400600609585. J Biopharm Stat. 2006. PMID: 16724488
Phase I studies of chemotherapeutic agents in cancer patients: a review of the designs.
Potter DM. Potter DM. J Biopharm Stat. 2006;16(5):579-604. doi: 10.1080/10543400600860295. J Biopharm Stat. 2006. PMID: 17037260 Review.
A permutation test for inference in logistic regression with small- and moderate-sized data sets.
Potter DM. Potter DM. Stat Med. 2005 Mar 15;24(5):693-708. doi: 10.1002/sim.1931. Stat Med. 2005. PMID: 15515134
Omnibus permutation tests of the association of an ensemble of genetic markers with disease in case-control studies.
Potter DM. Potter DM. Genet Epidemiol. 2006 Jul;30(5):438-46. doi: 10.1002/gepi.20155. Genet Epidemiol. 2006. PMID: 16671109
Adaptive dose finding for phase I clinical trials of drugs used for chemotherapy of cancer.
Potter DM. Potter DM. Stat Med. 2002 Jul 15;21(13):1805-23. doi: 10.1002/sim.1141. Stat Med. 2002. PMID: 12111891
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Carneiro BA, Ramanathan RK, Fakih MG, Krishnamurthi SS, Lembersky BC, Stoller RG, Lancaster SL, Pinkerton RA, Crandall TL, Schmotzer AR, Potter DM, Bahary N. Carneiro BA, et al. Among authors: potter dm. Clin Colorectal Cancer. 2012 Mar;11(1):53-9. doi: 10.1016/j.clcc.2011.05.003. Epub 2011 Aug 2. Clin Colorectal Cancer. 2012. PMID: 21813336 Clinical Trial.
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
Ramalingam SS, Egorin MJ, Ramanathan RK, Remick SC, Sikorski RP, Lagattuta TF, Chatta GS, Friedland DM, Stoller RG, Potter DM, Ivy SP, Belani CP. Ramalingam SS, et al. Among authors: potter dm. Clin Cancer Res. 2008 Jun 1;14(11):3456-61. doi: 10.1158/1078-0432.CCR-07-5088. Clin Cancer Res. 2008. PMID: 18519777 Clinical Trial.
A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
Zeh HJ 3rd, Brown CK, Holtzman MP, Egorin MJ, Holleran JL, Potter DM, Bartlett DL. Zeh HJ 3rd, et al. Among authors: potter dm. Ann Surg Oncol. 2009 Feb;16(2):385-94. doi: 10.1245/s10434-008-0179-5. Epub 2008 Nov 25. Ann Surg Oncol. 2009. PMID: 19034580 Clinical Trial.
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.
Ramanathan RK, Egorin MJ, Eiseman JL, Ramalingam S, Friedland D, Agarwala SS, Ivy SP, Potter DM, Chatta G, Zuhowski EG, Stoller RG, Naret C, Guo J, Belani CP. Ramanathan RK, et al. Among authors: potter dm. Clin Cancer Res. 2007 Mar 15;13(6):1769-74. doi: 10.1158/1078-0432.CCR-06-2233. Clin Cancer Res. 2007. PMID: 17363531 Clinical Trial.
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers.
Ramanathan RK, Trump DL, Eiseman JL, Belani CP, Agarwala SS, Zuhowski EG, Lan J, Potter DM, Ivy SP, Ramalingam S, Brufsky AM, Wong MK, Tutchko S, Egorin MJ. Ramanathan RK, et al. Among authors: potter dm. Clin Cancer Res. 2005 May 1;11(9):3385-91. doi: 10.1158/1078-0432.CCR-04-2322. Clin Cancer Res. 2005. PMID: 15867239 Clinical Trial.
98 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback